Clinical study of psychological intervention combined with bisoprolol and trimetazidine in the treatment of heart failure with left ventricular ejection fraction
10.3969/j.issn.1005-1678.2017.09.053
- VernacularTitle:心理干预联合比索洛尔、曲美他嗪治疗左心室射血分数保留的心力衰竭的临床研究
- Author:
Meiqin CHEN
;
Yinjuan FANG
- Keywords:
left ventricular ejection fraction;
psychological intervention;
trimetazidine;
bisoprolol;
clinical efficacy
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(9):126-128
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the clinical effect of psychological intervention combined with trimetazidine and bisoprolol in the treatment of left ventricular ejection fraction with heart failure. Methods 40 patients with heart failure were enrolled in this study. 40 patients were divided into control group and study group by digital randomization. There were 20 patients in each group and the patients in the control group.The patients were treated with trimetazidine and bisoprolol. The study group was treated with psychological intervention on the basis of the treatment. The clinical efficacy, adverse reactions, left ventricular ejection fraction and anxiety self-rating were analyzed (SAS), self-rating depression scale (SDS) score. Results The total effective rate of the clinical treatment group was 90.00％ higher than that of the control group (70.00％)P<0.05. There was no significant difference between the two groups in the adverse reaction. The mean left ventricular ejection fraction of the study group was (40.25 ± 5.24), which was significantly lower than that of the control group (43.92 ± 5.30). The scores of the study group were (50.26 ± 1.35) and (51.38 ± 2.61) respectively in SAS and SDS scores (54.36 ± 2.60), (56.98 ± 3.25) in the control group, (P<0.05). Conclusion The patients with left ventricular ejection fraction retention psychological failure in the application of trimetazidine, bisoprolol treatment based on the necessary psychological intervention, can effectively improve the patient's negative emotions, improve patient compliance, and then improve clinical efficacy, clinical significant application value.
